I'rom Group Co., Ltd. engages in the medical support business. It operates through five reportable segments: Advanced Medical Business, Site Management Organization (SMO) Business, Contract Research Organization (CRO) Business, Drug Discovery Business and Medical Support Business. Advanced Medical Business is that applies superior vector technology to develop vaccines and gene therapy preparations, and develops, manufactures and sells products in the field of regenerative medicine. SMO Business are commissioned by medical institutions to carry out some of the work related to the implementation of clinical trials, and act on their behalf and provide support. CRO Business involves accepting all or part of the work related to clinical trials from pharmaceutical companies and other entities and acting on their behalf and providing support. Drug Discovery Business involves the joint development of important, highly effective pharmaceuticals, such as biosimilars, based on license agreements and other agreements with pharmaceutical companies, both domestic and overseas. Medical Support Business is a business that provides general and comprehensive support for medical practice management, including the establishment and rental of clinic malls, product sales, and other related services. The company was founded on April 9, 1997 and is headquartered in Tokyo, Japan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company